Australien - Englisch - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - lacosamide, quantity: 100 mg - tablet, film coated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; hyprolose; crospovidone; microcrystalline cellulose; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 6000; macrogol 400 - lacoress (lacosamide) tablets are indicated as: ? monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older. ? add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older. ? add-on therapy in the treatment of primary generalised tonic-clonic seizures in patients with idiopathic generalised epilepsy aged 4 years and older.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - lacosamide, quantity: 200 mg - tablet, film coated - excipient ingredients: hyprolose; crospovidone; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; titanium dioxide; hypromellose; purified talc; macrogol 6000; macrogol 400; indigo carmine aluminium lake - lacoress (lacosamide) tablets are indicated as: ? monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older. ? add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older. ? add-on therapy in the treatment of primary generalised tonic-clonic seizures in patients with idiopathic generalised epilepsy aged 4 years and older.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - lacosamide, quantity: 150 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; hyprolose; crospovidone; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 6000; iron oxide red; iron oxide black; macrogol 400 - lacoress (lacosamide) tablets are indicated as: ? monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older. ? add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older. ? add-on therapy in the treatment of primary generalised tonic-clonic seizures in patients with idiopathic generalised epilepsy aged 4 years and older.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - lacosamide, quantity: 50 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; hyprolose; colloidal anhydrous silica; crospovidone; magnesium stearate; titanium dioxide; hypromellose; purified talc; macrogol 6000; iron oxide red; iron oxide black; macrogol 400; indigo carmine aluminium lake - lacoress (lacosamide) tablets are indicated as: ? monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older. ? add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older. ? add-on therapy in the treatment of primary generalised tonic-clonic seizures in patients with idiopathic generalised epilepsy aged 4 years and older.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

viiv healthcare pty ltd - cabotegravir, quantity: 30 mg (equivalent: cabotegravir sodium, qty mg) - tablet, film coated - excipient ingredients: titanium dioxide; magnesium stearate; hypromellose; lactose monohydrate; microcrystalline cellulose; sodium starch glycollate type a; macrogol 3350 - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna <50 copies/ml) and have no known or suspected resistance to either cabotegravir or rilpivirine (see sections 4.2 dose and method of administration and 5.1 pharmacodynamic properties, clinical trials) for: ? oral lead in to assess tolerability of cabotegravir prior to administration of cabotegravir prolonged-release suspension for injection plus rilpivirine prolonged-release suspension for injection. ? oral therapy for adults who will miss planned dosing with cabotegravir prolonged-release suspension for injection.

Philippinen - Englisch - FDA (Food And Drug Administration)

unilab, inc. - multivitamins , iron - film-coated tablet - each film-coated tablet contains: iron, elemental (equivalent to 320 mg ferrous fumarate) 105mg dl-alpha tocopheryl acetate (vitamin e) 30 i.u. thiamine mononitrate (vitamin b1) 10mg riboflavin (vitamin b2) 10mg pyridoxine hydrochloride (vitamin b6) 5mg cyanocobalamin (vitamin b12) 50mcg nicotinamide (vitamin b3) 30mg sodium ascorbate 500mg

Philippinen - Englisch - FDA (Food And Drug Administration)

glaxosmithkline consumer healthcare philippines, inc.; distributor: glaxosmithkline consumer healthcare philippines, inc. - multivitamins , iron - film coated tablet - formulation each film-coated tablet contains: thiamine hydrochloride (vitamin b1) 15 mg riboflavin (vitamin b2) 10 mg nicotinamide pantothenic acid (as calcium pantothenate)100 mg pyridoxine (as hydrochloride) (vitamin b6) 5 mg biotin 45 mcg folic acid 400 mcg cyanocobalamin (vitamin b12) 12 mcg ascorbic acid (vitamin c) 500 mg dl-alpha tocopheryl acetate (vitamin e) 30 iu iron (as ferrous fumarate) 27 mg

Philippinen - Englisch - FDA (Food And Drug Administration)

glaxosmithkline consumer healthcare philippines, inc.; distributor: interphil laboratories, inc. - multivitamins , iron - film coated tablet - formulation each film-coated tablet contains: thiamine hydrochloride (vitamin b1)15 mg riboflavin (vitamin b2)10 mg nicotinamide 100 mg pantothenic acid (as calcium pantothenate)20 mg pyridoxine (as hydrochloride) (vitamin b6)5 mg biotin 45 mcg folic acid 400 mcg cyanocobalamin (vitamin b12)12 mcg ascorbic acid (vitamin c)500 mg dl-alpha tocopheryl a5cetate (vitamin e)30 iu ron (as ferrous fumarate) 327 mg

Philippinen - Englisch - FDA (Food And Drug Administration)

n/a; importer: lakeside pharmaceuticals phil., inc.; distributor: lakeside pharmaceuticals phil., inc. - multivitamins,minerals,ginseng,amino acids - film-coated tablet - formulation: each film-coated tablet contains highly standardized ginseng dry extract-50mg retinol (as acetate) [vitamin a]-3250iu thiamine (as hci) [ vitamin b1]-10.7mg riboflavin (vitamin b2)-5.5mg pyridoxine (as hci) [vitamin b6]-5.7mg cyanocobalamin (vitamin b12)-15mcg cholecalciferol (vitamin d3)-400iu alpha-tocopherol acetate (vitamin e)-7.5iu biotin (vitamin h)-500mcg nicotinamide-27.5iu folic acid-800mg inositol-7.5mg lysine (as hci)-240mcg glutamic acid-500mcg iron-5mg calcium-38.8mg potassium-5mg copper-100mcg manganese-330mcg magnesium-1mg zinc-500mcg phosphorus-20mg iodine-50mcg

Philippinen - Englisch - FDA (Food And Drug Administration)

pharma nutria n.a., inc. - multivitamins , paracetamol - film-coated tablet - each film coated tablet: thiamine mononitrate (vitamin b1) 150 mg pyridoxine hydrochloride (vitamin b6) 100 mg cyanocobalamin (vitamin b12) 3000 mcg paracetamol 600 mg